Literature DB >> 29030135

Staphylococcus saprophyticus: Which beta-lactam?

Hélène Pailhoriès1, Viviane Cassisa2, Rachel Chenouard2, Marie Kempf2, Matthieu Eveillard2, Carole Lemarié2.   

Abstract

BACKGROUND: Staphylococcus saprophyticus is resistant to the drugs most often used for the empirical treatment of urinary tract infections (UTI). The adequacy of antimicrobial treatments prescribed for UTI due to S. saprophyticus is not usually questioned. This study described the epidemiology of such infections and assessed the susceptibility of S. saprophyticus to ceftriaxone and amoxicillin-clavulanic acid.
METHODS: Methicillin-susceptible S. saprophyticus (MSSS) isolated from clinical samples between November 2014 and July 2016 were included. Clinical data were recorded. The minimum inhibitory concentrations (MICs) of amoxicillin-clavulanic acid and ceftriaxone were measured for these MSSS strains and for 17 randomly selected methicillin-susceptible Staphylococcus aureus (MSSA) strains.
RESULTS: Of the S. saprophyticus isolates from urine, 59.5% were associated with a diagnosis of cystitis and 33.3% with pyelonephritis. Sixty percent of S. saprophyticus cystitis cases and 25% of pyelonephritis cases were given an inappropriate antibiotic regimen. The MICs of ceftriaxone ranged from 4 to >32μg/ml for MSSS, and from 1.5 to 4μg/ml for MSSA.
CONCLUSIONS: Many UTIs were treated with an empirical antibiotic therapy that was ineffective for S. saprophyticus, revealing that S. saprophyticus is an aetiology that is insufficiently considered in UTI. High MICs for ceftriaxone in MSSS were observed, which raises questions about the use of this antibiotic in UTIs due to S. saprophyticus.
Copyright © 2017 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Amoxicillin–clavulanic acid; Beta-lactams; Ceftriaxone; Minimum inhibitory concentrations; Staphylococcus saprophyticus

Mesh:

Substances:

Year:  2017        PMID: 29030135     DOI: 10.1016/j.ijid.2017.10.001

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  4 in total

1.  Susceptibility of Methicillin-Resistant Staphylococcus aureus to Five Quinazolinone Antibacterials.

Authors:  Sara Ceballos; Choon Kim; Yuanyuan Qian; Shahriar Mobashery; Mayland Chang; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  In Silico Subtractive Proteomics Approach for Identification of Potential Drug Targets in Staphylococcus saprophyticus.

Authors:  Farah Shahid; Usman Ali Ashfaq; Sania Saeed; Samman Munir; Ahmad Almatroudi; Mohsin Khurshid
Journal:  Int J Environ Res Public Health       Date:  2020-05-22       Impact factor: 3.390

3.  Pyelonephritis-associated Staphylococcus saprophyticus bacteremia in an immunocompetent host: Case report and review of the literature.

Authors:  Ahmad Matarneh; Gawahir A Ali; Wael Goravey
Journal:  Clin Case Rep       Date:  2021-12-05

4.  Clinical characteristics and prediction analysis of pediatric urinary tract infections caused by gram-positive bacteria.

Authors:  Yu-Lung Hsu; Shih-Ni Chang; Che-Chen Lin; Hsiao-Chuan Lin; Huan-Cheng Lai; Chin-Chi Kuo; Kao-Pin Hwang; Hsiu-Yin Chiang
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.